Selected out of 60+ publications
1. Fracture Risk Assessment in Clinical Practice: Why Do It? What to Do It With? Chandran M.J Clin Densitom. 2017 Jul - Sep;20(3):274-279
2. Diabetes Drug Effects on the Skeleton.Chandran M. Calcif Tissue Int. 2017 Feb;100(2):133-149.
3. Mechanisms of diabetes mellitus-induced bone fragility. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL; IOF Bone and Diabetes Working Group.Nat Rev Endocrinol. 2017 Apr;13(4):208-219
4. A Retrospective Review of Imaging and Operative Modalities Performed in Patients with Primary Hyperparathyroidism at a Mid-Volume Surgical Centre in Southeast Asia.Tan MZ, Ng JC, Eisman JA, Ng DC, Hansen L, Chandran M. Ann Acad Med Singapore. 2016 May;45(5):191-7.
5. Surgery or no surgery: What works best for the kidneys in primary hyperparathyroidism? A study in a multi-ethnic Asian population.Tay YK, Khoo J, Chandran M. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):55-61
6. AXIAL BMD IN DIABETIC AND NONDIABETIC SOUTHEAST ASIANS WITH HIP FRACTURES: DO RACE AND BODY MASS INDEX MATTER? Chandran M, Tay D, Tan M, Hao Y, Huang XF, Khoo J, Puar TH. Endocr Pract. 2016 Jun;22(6):716-25
Lead Investigator in the Evolution of Trabecular Bone Score following Renal Transplantation funded by the Lee Foundation Singhealth Transplant Grant
Principal Investigator from Singapore General Hospital for the Asia Latin America Fracture Observation Study
